Tag: Agreement
Healthium Medtech & HSSC sign MoU to enhance skill development in...
Strategic partnership to offer specialized training and certification programs for skilling, reskilling and upskilling healthcare professionals across India
OmniActive acquires ENovate Biolife
This transaction marks OmniActive’s second strategic expansion, following its purchase of Bangalore-based botanical ingredients company IndFrag in 2017
Biocon Biologics secures market entry for its Bmab 1200 Biosimilar in...
Under the terms of this settlement agreement, Biocon Biologics has resolved patent disputes with Janssen to secure market entry dates in Europe, the UK, Canada, and Japan
Alkem MedTech partners Exactech to manufacture & market knee-hip replacement implants...
This collaboration marks the first of its kind in the musculoskeletal space in India, providing Alkem MedTech with access to the design, manufacturing expertise, and marketing rights of Exactech's globally-recognized brands
GSK acquires oligonucleotide drug startup Elsie
This follows a successful research collaboration with Elsie, announced in July 2023, in which GSK was able to explore and validate the technology
Glenmark to sell BeiGene’s oncology medicines, Tislelizumab and Zanubrutinib in India
Under this strategic collaboration, Glenmark will be responsible for locally required development, registration and distribution providing access to BeiGene's innovative oncology medicines for cancer patients across India
Revvity signs new license agreement with AstraZeneca for Next-Gen Base Editing...
Non-exclusive agreement provides AstraZeneca access to proprietary gene editing technology to help advance its work in cell therapy
BSV forges collaboration with NCL-Pune to co-develop biopharma products
This collaboration primarily focuses on evaluation of certain recombinant cell line technologies developed by NCL for biopharmaceutical products currently under development at BSV
Lupin signs distribution agreement with Medis for orphan drug, NaMuscla
Agreement enables expanded patient access of the only EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders in Central and Eastern European territories
Cipla signs COVID-19 drug licensing deal with MSD
Cipla enters into a licensing agreement with MSD to expand access to the investigational oral therapeutic drug for COVID-19 treatment...........................